NewAmsterdam Pharma Company N.V. (NAMS) Operating cash flow 2021–2025
NewAmsterdam Pharma Company N.V. (NAMS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$147.8MFY2025 · since FY2021: -$29.5M → -$147.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$147.8M | +6.8% |
| FY2024 | -$158.6M | -12.3% |
| FY2023 | -$141.2M | -1424.1% |
| FY2022 | $10.7M | +136.1% |
| FY2021 | -$29.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice